by Medscape
The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine.
Language
🇺🇲
Publishing Since
11/26/2013
Email Addresses
1 available
Phone Numbers
0 available
April 10, 2025
<p>A panel discussion of a Presidential Advisory from the American Heart Association that outlines the importance of funding for scientific research and the need for a robust National Institutes of Health.</p> <p>This podcast is intended for healthcare professionals only.</p> <p>To read a transcript or to comment, visit</p> <p>https://www.medscape.com/author/bob-harrington</p> <p>INCLUDE URLS and full titles for some of the pertinent studies cited.</p> <p>You may also like:</p> <p>Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association</p> <p>https://doi.org/10.1161/cir.0000000000001319</p> <p>The Role of Public-Sector Research in the Discovery of Drugs and Vaccines."</p> <p>https://www.nejm.org/doi/full/10.1056/NEJMsa1008268</p> <p>Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019</p> <p>https://pubmed.ncbi.nlm.nih.gov/37115539/</p> <p>Hear John Mandrola, MD's summary and perspective on the top cardiology news each week on This Week in Cardiology</p> <p>https://www.medscape.com/twic</p> <p>Questions or feedback, please contact [email protected]</p>
January 30, 2025
<p>Drs Harrington and Gibson review their picks for the top cardiology trials of 2024 and look ahead to 2025, particularly what health topics may be prioritized by the new administration.</p> <p>This podcast is intended for healthcare professionals only.</p> <p>To read a transcript or to comment https://www.medscape.com/author/bob-harrington</p> <p>Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction (REDUCE AMI) https://www.nejm.org/doi/abs/10.1056/NEJMoa2401479</p> <p>Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD) https://doi.org/10.1056/nejmoa2412006</p> <p>Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis EARLY TAVR https://www.nejm.org/doi/full/10.1056/NEJMoa2405880</p> <p>Asundexian versus Apixaban in Patients with Atrial Fibrillation (OCEANIC-AF) https://doi.org/10.1056/NEJMoa2407105</p> <p>In the Wake of OCEANIC-AF, Is Equipoise Regarding Factor XI Inhibition Still Afloat? https://www.jacc.org/doi/10.1016/j.jacc.2024.10.105</p> <p>Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial https://doi.org/10.1016/S0140-6736(24)00413-6</p> <p>Preventive Coronary Stents: Not There Yet</p> <p> https://www.medscape.com/viewarticle/preventive-coronary-stents-not-there-yet-2024a10006yr</p> <p>Speech by Commissioner Robert M. Califf to the House of Medicine June 16, 2023</p> <p> https://www.fda.gov/news-events/speeches-fda-officials/speech-commissioner-robert-m-califf-house-medicine-06162023</p> <p>Evolution of Single-Lead ECG for STEMI Detection Using a Deep Learning Approach</p> <p>https://doi.org/10.1016/j.ijcard.2021.11.039</p> <p>From ST-Segment Elevation MI to Occlusion MI: The New Paradigm Shift in Acute Myocardial Infarction https://doi.org/10.1016/j.jacadv.2024.101314</p> <p>You may also like:</p> <p>Hear John Mandrola, MD’s summary and perspective on the top cardiology news each week, on This Week in Cardiology</p> <p>https://www.medscape.com/twic</p> <p>Questions or feedback, please contact [email protected]</p>
December 10, 2024
Cardiologists Bob Harrington, Manesh Patel, and Michael Gibson discuss whether the ST-segment elevation myocardial infarction paradigm needs an update to 'Occlusion MI', offering new insights for healthcare professionals.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
